Literature DB >> 15322868

Hypertension induced reversible posterior leukoencephalopathy syndrome: a report of two cases.

Z Birsin Ozcakar1, Mesiha Ekim, Suat Fitoz, Serap Teber, Selda Hizel, Banu Acar, Selcuk Yüksel, Fatos Yalcinkaya.   

Abstract

UNLABELLED: Reversible posterior leukoencephalopathy syndrome (RPLS) is a recently described disorder with typical radiological findings of bilateral grey and white matter abnormalities in the posterior regions of the cerebral hemispheres. The majority of patients with RPLS are adults and it is rare in children. In this report, two patients with RPLS are presented. In the first patient the primary diagnosis was acute post-streptococcal glomerulonephritis, a known cause of RPLS both in adults and in children. The second patient had Henoch Schönlein purpura.
CONCLUSION: These patients are presented to highlight the importance of reversible posterior leukoencephalopathy syndrome. As the spectrum of associated diseases is diverse, paediatricians must be aware of this syndrome in order to initiate appropriate management.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15322868     DOI: 10.1007/s00431-004-1532-8

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  10 in total

1.  Pontine reversible edema: a newly recognized imaging variant of hypertensive encephalopathy?

Authors:  S O Casey; C L Truwit
Journal:  AJNR Am J Neuroradiol       Date:  2000-02       Impact factor: 3.825

2.  Cerebral vasculitis in Henoch-Schönlein purpura.

Authors:  S A Bakkaloğlu; M Ekim; N Tümer; G Deda; I Erden; T Erdem
Journal:  Nephrol Dial Transplant       Date:  2000-02       Impact factor: 5.992

3.  Reversible posterior leukoencephalopathy in a patient with minimal-change nephrotic syndrome.

Authors:  M Ikeda; S Ito; H Hataya; M Honda; K Anbo
Journal:  Am J Kidney Dis       Date:  2001-04       Impact factor: 8.860

4.  [Posterior leukoencephalopathy reversible syndrome secondary to panarteritis nodosa].

Authors:  P Laguna; T Martín; M J Marchena; M Moya
Journal:  Med Clin (Barc)       Date:  1997-09-27       Impact factor: 1.725

5.  The reversible posterior cerebral edema syndrome.

Authors:  W P Dillon; H Rowley
Journal:  AJNR Am J Neuroradiol       Date:  1998-03       Impact factor: 3.825

6.  Posterior leukoencephalopathy syndrome may not be reversible.

Authors:  N L Antunes; T N Small; D George; F Boulad; E Lis
Journal:  Pediatr Neurol       Date:  1999-03       Impact factor: 3.372

7.  Posterior leukoencephalopathy syndrome in poststreptococcal acute glomerulonephritis.

Authors:  A Soylu; S Kavukçu; M Türkmen; Y Akbaş
Journal:  Pediatr Nephrol       Date:  2001-07       Impact factor: 3.714

8.  Clinical spectrum of reversible posterior leukoencephalopathy syndrome.

Authors:  S Kwon; J Koo; S Lee
Journal:  Pediatr Neurol       Date:  2001-05       Impact factor: 3.372

9.  Is reversible posterior leukoencephalopathy with severe hypertension completely reversible in all patients?

Authors:  Narayan Prasad; Sanjeev Gulati; Rakesh Kumar Gupta; Rajesh Kumar; Kumudini Sharma; Raj Kumar Sharma
Journal:  Pediatr Nephrol       Date:  2003-09-19       Impact factor: 3.714

10.  A reversible posterior leukoencephalopathy syndrome.

Authors:  J Hinchey; C Chaves; B Appignani; J Breen; L Pao; A Wang; M S Pessin; C Lamy; J L Mas; L R Caplan
Journal:  N Engl J Med       Date:  1996-02-22       Impact factor: 91.245

  10 in total
  15 in total

1.  Henoch-Schönlein purpura nephritis complicated by reversible posterior leukoencephalopathy syndrome.

Authors:  Daimei Sasayama; Yasuhiro Shimojima; Takahisa Gono; Kazuma Kaneko; Masayuki Matsuda; Shu-ichi Ikeda
Journal:  Clin Rheumatol       Date:  2007-01-05       Impact factor: 2.980

Review 2.  Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features.

Authors:  W S Bartynski
Journal:  AJNR Am J Neuroradiol       Date:  2008-03-20       Impact factor: 3.825

Review 3.  Posterior reversible encephalopathy syndrome in Henoch-Schönlein purpura.

Authors:  Sebastiano A G Lava; Gabriëlla G A M Peeters; Mario G Bianchetti; Barbara Goeggel Simonetti; Giacomo D Simonetti; Gregorio P Milani
Journal:  Rheumatol Int       Date:  2016-10-21       Impact factor: 2.631

Review 4.  Posterior reversible encephalopathy syndrome in children with kidney disease.

Authors:  Cristina Gavrilovici; Ingrith Miron; Luminiţa Voroneanu; Silvia Bădărau; Magdalena Stârcea
Journal:  Int Urol Nephrol       Date:  2017-08-23       Impact factor: 2.370

5.  Tumor lysis syndrome as a contributory factor to the development of reversible posterior leukoencephalopathy.

Authors:  A Ozkan; B Hakyemez; F Ozkalemkas; R Ali; V Ozkocaman; T Ozcelik; O Taskapilioglu; Y Altundal; A Tunali
Journal:  Neuroradiology       Date:  2006-09-16       Impact factor: 2.804

Review 6.  Posterior reversible encephalopathy syndrome in children with kidney diseases.

Authors:  Kenji Ishikura; Yuko Hamasaki; Tomoyuki Sakai; Hiroshi Hataya; Robert H Mak; Masataka Honda
Journal:  Pediatr Nephrol       Date:  2011-05-11       Impact factor: 3.714

7.  Posterior reversible encephalopathy in a child with Langerhans cell histiocytosis following allogeneic PBSCT treatment with cyclosporine.

Authors:  Chi-Chieh Lai; Shyi-Jou Chen; Shao-Hung Lien; Chung-Ping Lo; Shin-Nang Cheng
Journal:  Eur J Pediatr       Date:  2007-07-26       Impact factor: 3.183

Review 8.  Reversible posterior leukoencephalopathy syndrome in childhood: report of nine cases and review of the literature.

Authors:  Hakan Gümüş; Hüseyin Per; Sefer Kumandaş; Ali Yikilmaz
Journal:  Neurol Sci       Date:  2009-10-07       Impact factor: 3.307

9.  Posterior reversible encephalopathy syndrome in a child with Henoch-Schonlein purpura.

Authors:  Ali Kemal Sivrioglu; Mehmet Incedayi; Hakan Mutlu; Cihan Meral
Journal:  BMJ Case Rep       Date:  2013-08-14

10.  Posterior reversible encephalopathy syndrome and the pediatric population.

Authors:  Prasant Peter; Ann George
Journal:  J Pediatr Neurosci       Date:  2012-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.